Dear Members,
Your directors have pleasure in presenting the 1st Annual
Report together with the Audited Statement of Accounts of your Company for the financial
Year ended March 31, 2024.
1. FINANCIAL SUMMARY:
The Company's financial performance for the financial year ended
March 31, 2024: (Amount in Rs.100)
| Particulars |
Year ended March 31, 2024 |
| Revenue from Operations |
- |
| Other Income |
- |
| Total Income |
- |
| Less: Total Expenditure |
38000 |
| Profit Before Tax |
(38000) |
| Less: Current Tax |
- |
| Deferred Tax |
- |
| Income Tax earlier years |
- |
| Profit For The Year |
(38000) |
2. STATE OF AFFAIRS / HIGHLIGHTS:
During the period company don't achieved any Sales due to not
start any business. There is no any type of income in the financial Year 2023-24.
3. The Change In The Nature Of Business
The Company is engaged in the business of healthcare products. There
has been no change in the business of the Company during the financial year ended 31 st
March. 2024.
4. TRANSFER TO RESERVE:
The Board of Directors of your company has decided not to transfer
any/S?hount to the Reserves for the financial year under review. /
4. DIVIDEND
The company has not earned profit. Dividend not declared due to loss
for the financial year ended 31sl march, 2024.
5. TRANSFER OF UNCLAIMED DIVIDEND TO INVESTOR EDUCTION AND PROTECTION
FUND
The provisions of Section 125(2) of the Companies Act. 2013 do not
apply as Company didn't declared any dividend since incorporation.
6. MATERIAL CHANGES AND COMMITMENT IF ANY AFFECTING THE FINANCIAL
POSITION OF THE COMPANY OCCURRED BETWEEN THE END OF THE FINANCIAL YEAR TO WHICH THIS
FINANCIAL STATEMENTS RELATE AND THE DATE OF THE REPORT.
During the Current Financial year, the company is plaining to debut in
the primary market via introducing an Initial Public Offer (IPO) and accordingly, after
closure of Reporting Financial Year, the Company had decided to issue equity shares to
certain investors, in line with the Company's strategic goals, to raise capital for
the Company's expansion and operational needs.
During the Current Financial year, Company become the holding company
of the "Anondita Healthcare and Rubber Products India Private Limited" by
purchase the shares of the company as on lsl April, 2024.
There is no other material changes and commitment Which is affecting
the financial position of the company
7. DETAILS OF SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS
OR COURTS OR TRIBUNALS IMPACTING THE GOING CONCERN STATUS AND COMPANY'S OPERATION IN
FUTURE
No such orders have been passed by any authority.
8. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE
EARNINGS AND OUTGO
(A) Conservation of Energy:
The activities of the Company are not energy intensive. Necessary steps
have already been taken to conserve the energy.
(B) Technology absorption:
The company engaged in the field of healthcare products. Hence the
company has not absorbed any technology.
(C) Foreign Exchange Earnings / Outgo:
There were no foreign exchange earnings or outflow during the year.
9. STATEMENT CONCERNING DEVELOPMENT AND IMPLEMENTATION OF RISK
MANAGEMENT POLICY OF THE COMPANY
The Company has in place a mechanism to identify, assess, monitor and
mitigate various risks to key business objectives. Major risks identified by the business
and functions are systematically addressed through mitigating actions on a continuing
basis.
10. DETAILS OF POLICY DEVELOPED AND IMPLEMENTED BY THE COMPANY ON ITS
CORPORATE SOCIAL RESPONSIBILITY INITIATIVES
The Company has not developed and implemented any Corporate Social
Responsibility initiatives as the said provisions are not applicable.
11. PARTICULARS OF LOANS. GUARANTEES OR INVESTMENTS MADE UNDER SECTION
186 OF THE COMPANIES ACT. 2013
There was no loan, guarantee or investment made by the Company under
Section 186 of the Companies Act, 2013 during the year under review and how'ever the said
provision is not applicable.
12. PARTICULARS OF CONTRACTS OR ARRANGEMENTS MADE WITH RELATED PARTIES
There is no transactions entered into with the related parties during
the financial year ended 31st March, 2024.
13. EXPLANATION OR COMMENTS ON QUALIFICATIONS. RESERVATIONS OR ADVERSE
REMARKS OR DISCLAIMERS MADE BY THE AUDITORS AND IN THEIR REPORTS
There was no qualification, reservations or adverse remarks made by the
Auditors in their report.
14. EXPLANATION OR COMMENTS ON QUALIFICATIONS, RESERVATIONS OR ADVERSE
REMARKS OR DISCLAIMERS MADE BY THE PRACTICING COMPANY SECRETARY IN THEIR REPORTS
The provisions relating to submission of Secretarial Audit Report is
not applicable to the Company.
15. COMPANY'S POLICY RELATING TO DIRECTORS APPOINTMENT, PAYMENT OF
REMUNERATION AND DISCHARGE OF THEIR DUTIES
During the Financial year 31st March, 2024, the company is
not covered under sub-section (1) of section 178.
Later on. Company is plaining to debut in the primary market via
introducing an Initial Public Offer (IPO) and accordingly, the clause under sub-section
(1) of section 178 become applicable. However, the Company has formulated the NRC and its
policy after closure of Reporting Financial Year.
Also appoint the Managing Director, Whole time Directors, Independent
Directors in its Board and Other KMP(s) in the company in accordance with the provisions
of Section 203 of the Companies Act, 2013 and Securities Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 as follow:
| Name of Director/ KMP |
Designation |
Date of Appointment |
| Mr. Anupam Ghosh |
Managing Director |
15/05/2024 |
| Mr. Reshant Ghosh |
Whole Time Director |
15/05/2024 |
| Ms. Sonia Ghosh |
Whole Time Director |
15/05/2024 |
| Ms. Nishi Goel |
Independent Director |
15/05/2024 |
| Mr. Gaurav Kumar |
Independent Director |
29/06/2024 |
| Mr. Lakhinder Singh |
Non-Executive Director |
29/06/2024 |
| Ms. Sunita Naithani |
Chief Financial Officer |
15/05/2024 |
| Ms. Nutan Agrawal |
Company Secretary |
15/05/2024 |
16. MEETINGS OF BOARD OF DIRECTORS:
Two (2) Board Meetings were held during the Financial Year 2023-2024.
The agenda and Notice for the meetings were prepared and circulated in advance to the
Directors. The intervening gap between the meetings was within the time period prescribed
under the Companies Act, 2013.
17. COMPLIANCE WITH SECRETARIAL STANDARD:
The Company has Complied with the applicable Secretarial Standards (as
amended from time to time) on meetings of the Board of Directors issued by The Institute
of Company Secretaries of India and approved by Central Government under section 118(10)
of the Companies Act, 2013.
18. DIRECTORS RESPONSIBILITY STATEMENT
In accordance with the provisions of Section 134(5) of the Companies
Act. 2013 the Board hereby submit its responsibility Statement:
(a) in the preparation of the annual accounts, the applicable
accounting standards had been followed along with proper explanation relating to material
departures.
(b) the directors had selected such accounting policies and applied
them consistently and made judgments and estimates that are reasonable and prudent so as
to give a true and fair view of the state of affairs of the company at the end of the
financial year and of the profit and loss of the company for that period;
(c) the directors had taken proper and sufficient care for the
maintenance of adequate accounting records in accordance with the provisions of this Act
for safeguarding the assets of the company and for preventing and detecting fraud and
other irregularities;
(d) the directors had prepared the annual accounts on a going concern
basis; and
(e) the directors had devised proper systems to ensure compliance with
the provisions of all applicable laws and that such systems were adequate and operating
effectively.
19. SUBSIDIARIES, JOINT VENTURES AND ASSOCIATE COMPANIES
The Company has not any Subsidiary. Joint venture or Associate Company
during the Financial Year ended 31st March. 2024.
As on 1st April, 2024 Company enter into the Share Purchase
agreement with the Group Company "Anondita Healthcare and Rubber Products India
private Limited" Hence created the Holding and Wholly Owned Subsidiary relationship
with the Anondita Healthcare and Rubber Products India private Limited"
from lsl April, 2024.
Later on 'Anondita Healthcare and Rubber Products India
private Limited" convert into Subsidiary from Wholly Owned Subsidiary due to issue
and allotted new shares to certain Investors Via preferential Issue of the company.
20. DIRECTORS
There has not been change in the constitution of the Board of Directors
during the year under review. The First Director of the company are following:
| Director's Name |
DIN |
Date of Appointment |
| Mr. Anupam Ghosh |
02675517 |
12/03/2024 |
| Ms. Sonia Ghosh |
02717906 |
12/03/2024 |
| Mr. Reshant Ghosh |
08632812 |
12/03/2024 |
21. DEPOSITS
The Company has neither accepted nor renewed any deposits covered under
Chapter V of the Companies Act, 2013 during the year under review.
22. DECLARATION OF INDEPENDENT DIRECTORS
The provisions of Section 149 pertaining to the appointment of
Independent Directors do not apply to our Company during the Financial Year ending 31st
March. 2024.
Later on, Company is plaining to debut in the primary market via
introducing an Initial Public Offer (IPO) and however, Company is complied with the
provision of Section 149 pertaining to the appointment of Independent Directors and
appoint the Independent Directors as follow:
| Name of Director/ KMP |
Designation |
Date of Appointment |
| Mr. Gaurav Kumar |
Independent Director |
29/06/2024 |
| Ms. Nishi Goel |
Independent Director |
15/05/2024 |
23. STATUTORY AUDITORS
M/s Jain Chopra & Company, Chartered Accountants (having FRN:
002198N) appointed as first statutory auditor of the company as on 9th
April, 2024 for holding statutory audit for the period from 12th March, 2024 to
31sl March, 2024, The Board has recommend him for reappointment for further
period of 5 years to conduct the Statutory audit from 1st April, 2024 till 31st
March, 2029.
The Notes to Accounts referred to in the Auditors' Report are
self-explanatory and therefore do not call for any further comments. The Auditors'
report does not contain any qualification, reservation or adverse remark.
24. DETAILS IN RESPECT OF FRAUDS REPORTED BY AUDITORS UNDER SUBSECTION
(121 OF SECTION 143 OTHER THAN THOSE REPORTABLE TO THE CENTRAL GOVERNMENT
During the financial year under review, no such fraud was reported.
25. MAINTENANCE OF COST RECORD
Maintenance of cost records as specified by the Central Government
under sub-section (1) of section 148 of the Companies Act, 2013, is not required by the
Company
26. INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY
Management has put in place effective Internal Control Systems to
provide reasonable assurance for:
Safeguarding Assets and their usage.
Maintenance of Proper Accounting Records and
Adequacy and Reliability of the information used for carrying on
Business Operations.
27. LOAN FROM BANKS
During the end of Financial year, company not apply for loan from any
the Banks or Financial Institutions however rule 8, in sub-rule (5) of the Companies
(Accounts) Amendment Rules, 2021 not applicable on the company.
28. DISCLOSURE UNDER SEXUAL HARASSMENT OF WOMEN AT WORKPLACE
(PREVENTION. PROHIBITION AND REDRESSAD ACT. 2013
During the reporting financial year, the provision of Sexual Harassment
of Women at Workplace (Prevention, Prohibition and Rcdrcssal) Act, 2013 is not applicable,
however, after closure of the Financial Year, as per the requirement of the Sexual
Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 (Act)
and rules made there under, your Company has adopted a Sexual Harassment Policy for women
to
ensure healthy working environment without fear of prejudice, gender
bias and sexual harassment.
The Board states that there were no cases or complaints filed pursuant
to the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Rcdressal)
Act, 2013 during the period after closure of the financial year till the date of the
approval of the Board Report.
29. DISCLOSURE OF COMPOSITION OF AUDIT COMMITTEE AND PROVIDING VIGIL
MECHANISM
.The provisions of Section 177 of the Companies Act, 2013 read with
Rule 6 and 7 of the Companies (Meetings of the Board and its Powers) Rules, 2 013 is not
applicable to the Company during the FY 2023-24.
Later on, Company is plaining to debut in the primary market via
introducing an Initial Public Offer (IPO) and however company complied with the provisions
of Section 177 of the Companies Act, 2013 and Constitute the Audit Committee as on 18th
August, 2024
30. A.NY PROCEEDING PENDING UNDER THE INSOLVENCY AM) BANKRUPTCY CODE,
2016 131 OF 2016)
During the year, neither any application has been made nor are any
proceedings initiated against and/or by the Company under the Insolvency and Bankruptcy
Code. 2016.
31. SHARES
A. BUY BACK OF SECURITIES
The Company has not bought back any of its securities during the year
under review'.
B. SWEAT EQUITY
The Company has not issued any Sw-eat Equity Shares during the year
under review.
C. BONUS SHARES
The Company has not issued any Bonus Shares during the year under
review.
D. EMPLOYEES STOCK OPTION PLAN
The Company has not provided any Stock Option Scheme to the employees
during the period under review.
32. CORPORATE GOVERNANCE:
The Company has adopted best corporate practices and is committed to
conducting its business in accordance with the applicable law's, rules and regulations.
The Company's Corporate Governance practices are driven by effective and strong Board
oversight, timely disclosures, transparent accounting policies and high level of Integrity
in decision making
33. ANNUAL RETURN
An Annual Return of your Company as referred in sub-section (3) of
section 92 of the Companies Act, 2013 read with the Companies (Management and
Administration) Rules, 2014, will be available on the website of the Company and the web
link of the same is www.anonditamedicare.com
34 Nomination And Remuneration Committee
During the reporting Financial year, the provision of Section 178 is
not applicable to your company, however, in the current financial year, your Company has
constituted Nomination and Remuneration Committee in accordance with the provisions of
Section 178 of Companies Act, 2013 and accordingly, the Committee presently consist three
Directors which are Non-Executive Independent Directors of the Company.
The Company Secretary of your Company will act as the Secretary of the
Committee.
Further, the detail Composition of the Nomination and Remuneration
Committee is given belgw: -
| S.no. |
Name of Director |
Nature of Directorship |
| 1 |
Mr.Gaurav Kumar |
Chairman (Independent Director) |
| 2 |
Ms. Nishi Goel |
Member (Independent Director) |
| 3 |
Mr. Lakhinder Singh |
Member (Non-Executive Director) |
STATEMENT BY THE BOARD WITH REGARD TO l.MECRlTV. EXPERTISE AND
EXPERIENCE OF THE INDEPENDENT DIRECTORS APPOINTED DURING THE YEAR
During the reporting financial year, the Board docs not consist of any
independent Director in its Board. How'ever, during the current financial year, your Board
has appointed certain Independent Directors and Your Board of Directors is satisfied about
the Integrity, Expertise and Experience including proficiency of the Independent Directors
has been appointed during the financial year under review in the Board of Directors of the
Company.
DETAILS OF DIFFERENCE BETWEEN AMOUNT OF THE VALUATION DONE AT THE TIME
OF ONE TIME SETTLEMENT AND THE VALUATION DONE WHILE TAKING LOAN FROM THE BANKS OR
FINANCIAL INSTITUTIONS ALONG WITH THE REASONS THEREOF
Your Company has not made any settlement with the Banks and Financial
Institutions. Therefore, there is nothing to report under this for the financial year
under review.
37 ACKNOWLEDGEMENT
Your diicctors place on the record their appreciation of the
Contribution made by employees, consultants at all levels, who with their competence,
diligence, solidarity, co-operation and support have enabled the Company to achieve the
desired results.
The boaid of Directors gratefully acknowledge the assistance and
co-operation received from the Central and State Governments Departments, Shareholders and
Stakeholders.